...
机译:患有糖尿病患者的生物降解的聚合物Sirovulumus洗脱支架术后六个与双抗血小板治疗疗法的六个与二元抗血小板治疗
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
Peoples Liberat Army Inst Cardiovasc Res Dept Cardiol Beijing Peoples R China;
机译:患有糖尿病患者的生物降解的聚合物Sirovulumus洗脱支架术后六个与双抗血小板治疗疗法的六个与二元抗血小板治疗
机译:在植入多种可生物降解的聚合物药物后,对患者进行6个月对12个月的双抗血小板治疗的安全性和疗效治疗冠状动脉支架从I-Love-IT 2试验中进行亚群分析
机译:六个与12个月的双抗血小板治疗植入植入生物降解的聚合物Siroverimus洗脱支架在老年患者中:亚群分析I-Love-IT 2审判
机译:营养治疗对妊娠期糖尿病患者血糖水平和妊娠结果的影响:META分析
机译:接受药物洗脱支架植入的糖尿病患者短期和长期双重抗血小板治疗:随机对照试验的荟萃分析
机译:TCT-81植入生物可降解聚合物西罗莫司洗脱支架后的六个月相对于十二个月的双重抗血小板治疗:I-LOVE-IT 2试验的随机亚组。